GlaxoSmithKline Vaccines President Luc Debruyne To Step Down
LONDON (Alliance News) - FTSE 100-listed GlaxoSmithKline PLC said on Tuesday Luc Debruyne, president of the Vaccines division will leave his role and the company at the end of 2018.He will Read More